A total of 16 phenolic compounds, including one new and five known N-cinnamoyl phenylethylamides, one new pyrrole alkaloid named portulacaldehyde, five phenylpropanoid acids and amides, and derivatives of benzaldehyde and benzoic acid, were isolated and identified from a polar fraction of an extract of Portulaca oleracea. Their structures were determined through spectroscopic analyses.
Portulaca oleracea L. (common purslane; Portulacaceae) is an annual, semi-succulent, trailing herbaceous plant. Folklore medicinal uses refer to its analgesic and wound-healing as well as anti-inflammatory properties, among a range of other uses [1, 2] . This species has occasionally been cultivated ornamentally or for use as a vegetable. Previous ethno-pharmacological results on the species have indicated that the anti-inflammatory activity could be observed through intraperitoneal or topical application, but not through oral administration, and the presence of anti-inflammatory compound(s) with high to medium polarity has been suggested [1, 2] . It was therefore considered that the active substances were low molecular weight compounds that could diffuse into the tissue and act locally. Following this rationale, we have fractionated a polar fraction of a methanol extract of the plant. This resulted in the identification of 16 compounds (1-16), including four new natural compounds of which two (9, 10) were known previously only as synthetic products (Figure 1 ). Their relevance to the traditional uses of P. oleracea is discussed in light of the known bioactivities of the compounds.
Compound 5 was obtained as a light brown glassy solid, with a molecular formula C 18 (Table 1) , two sets of resonances corresponding to 1,3,4-trisubstituted benzene rings, one transolefinic system (δ H 7.37 and 6.33 ppm, 1H each, d, J = 15.7 Hz), two triplet protons coupled to each other (δ H 2.72 and 3.46, 2H each, J = 7.4 Hz), and a sharp 3H singlet at δ H 3.81 ppm attributable to a methoxyl group were observed. The 13 C NMR spectrum (Table  1) showed 18 signals, including one carbonyl (δ C 169.4 ppm), four oxygenated quaternary carbons (δ C 146-149 ppm), and a methoxyl carbon at δ C 56.6 ppm. These, together with the long-range correlations detected in an HMBC spectrum (Figure 2 ), led to the identification of caffeoyl and (3-hydroxy-4-methoxyphenyl)ethyl moieties. The position of the methoxyl group was suggested by a correlation between the methoxy proton at δ H 3.81 ppm and C-4 at δ C 147.8 ppm in the HMBC spectrum, which was confirmed by an NOE enhancement of δ H 6.83 ppm (H-5, d, J = 8.2 Hz) upon irradiation of the methoxy proton. A correlation between the methylene protons at δ H 3.46 (H-8) and δ C at 169.4 (C-9') in the HMBC spectrum established the structure of 5 as
The structures of compounds 1, 3, and 4 were likewise elucidated with HRESIMS, 1D 1 H and 13 C NMR and 2D techniques (gCOSY, gHSQC and gHMBC), and selective NOE experiments were used to confirm the position of methoxyl groups. The NMR spectroscopic data for these compounds are presented in Table 1 , since those for 4 have not been reported previously, whereas those for 1 and 3 deviated considerably from existing literature assignments based on NMR spectra acquired in the same solvent [3] .
Among the six N-cinnamoyl phenylethylamides isolated in this study, only N-feruloyltyramine (3) has been reported from P. oleracea, as a constituent of the roots [4] ; however, roots were not explicitly stated to have been used in the systems of traditional medicine or subjected to pharmacological/clinical studies [1] .
Compound 7 was isolated as a pale yellow solid. Its molecular formula was established by HRESIMS and 1D 13 C NMR spectroscopic data as C 13 the remaining C 5 H 4 NO moiety consisted of four methine carbons one of which was that of an aldehyde (δ H 9.46 ppm; δ C 180.9 ppm), one quaternary carbon, and four degrees of unsaturation. Important correlations observed in the HMBC spectrum from δ H 4.44 (H-8') to δ C 132.5 (C-2) and δ C 134.0 (C-5), and those between methine protons and carbons (Figure 3a) ) led the partial structure to an N-substituted pyrrole-2-carboxaldehyde. The unusually high-field resonance of the aldehyde carbon (δ C 180.9 ppm) was consistent with its placement at the 2-rather than 3-position of the pyrrole ring [5, 6] . This was further confirmed by a series of selective NOE experiments where signal enhancements were observed from the aldehyde proton to δ H 7.01 (H-3) as well as from the latter to the former, and from the proton at δ H 4.44 (H-8') to both the aldehyde proton and δ H 6.91 (H-5) (Figure 3b ). The structure of 7 was therefore established as N- (3,4-dihydroxyphenylethyl) pyrrole-2-carboxaldehyde, which we name portulacaldehyde. This is only the second example of a compound having this skeleton following peyonine (= N-(3',4 ',5'-trimethoxyphenylethyl)pyrrole-2-carboxylic acid), found as a minor constituent of the psychoactive cactus Lophophora williamsii [7, 8] .
Compounds 9, 10, and 12 were identified as (E)-p-coumaramide, (E)-caffeamide and (E)-ferulamide, respectively. Their UV and NMR spectra were virtually identical to the corresponding acids; however, their respective molecular formulae C 9 H 9 NO 2 , C 9 H 9 NO 3 , and C 10 H 11 NO 3 , determined by HRESIMS, required substitution of one hydroxyl group in the acids each with an amino group. A consideration of the UV spectra and the 13 C chemical shift values of the heteroatom-bearing aromatic ring carbons (δ C 145-159 ppm) led to the structures of 9, 10, and 12 as amides. (E)-p-Coumaramide and (E)-caffeamide are here reported for the first time as natural compounds, while (E)-ferulamide has been isolated from ammoniatreated extracts of Hypecoum imberbe [9] and Glaucium grandiflorum var. grandiflorum [10] (details of isolation procedure in [11] ). The structures of known compounds were identified with HRESIMS data and 1D and 2D NMR spectra, as well as comparison with published data as: N-(E)-caffeoyltyramine (2) [12] , N-(E)-feruloyl 3-O-methyldopamine (6) [13] , (E)-p-coumaric acid (8) , (E)-ferulic acid (11), 4-hydroxybenzaldehyde (13), 2,4-dihydroxybenzaldehyde (14), 2-hydroxy-4-methoxybenzoic acid (15) , and syringic acid (16) [6] .
Compounds 2 [14] , 4 [14] [15] [16] , 13 [15] [16] [17] , and 14 [17, 18] have previously been reported to be involved in the regulation of inflammatory signal cascade and inhibition of key enzymes. The traditional use of P. oleracea as an anti-inflammatory agent, including as febrifuge and analgesic agents, may well be justified from these mechanisms.
Experimental
General: UV spectra were recorded on a UV-1601 spectrometer (Shimadzu; Kyoto, Japan). One-dimensional 1 H and 13 C nuclear magnetic resonance spectroscopy (NMR) and selective NOE, gCOSY, gHSQC, and gHMBC spectra were obtained on a Bruker Avance 400 MHz spectrometer (Rheinstetten, Germany) at 30°C, and the chemical shifts are given as δ values with reference to the residual solvent resonances (δ H 3.31 ppm and δ C 49.0 ppm in CD 3 OD, and δ H 2.50 ppm and δ C 39.5 ppm in DMSO-d 6 , calibrated to TMS at 0.00 ppm). High-resolution electrospray-ionization mass spectrometry (HRESIMS) data were recorded on an LTQ-Orbitrap XL instrument (Thermo Scientific; San Jose, CA, US). SemiAmides and alkaloid from Portulaca oleracea Natural Product Communications Vol. 7 (8) 2012 1049 preparative high-performance liquid chromatography (HPLC) was carried out for final purification of compounds using a Waters HPLC system (996 pump, 717 plus autosampler, and 2996 photodiode array detector; Milford, MA, US) with a Genesis C 18 column (10 mm diam. × 250 mm, 4 µm; Jones Chromatography, Mid Glamorgan, UK), at 30°C and at a flow rate of 4.0 mL/min.
Plant material: Air-dried aerial parts of P. oleracea were provided by Mr George He (HerbPrime Ltd, Salford, UK; batch HPMW5527) in October 2010, and the material was verified by Ms Christine Leon, RBG Kew. A representative specimen was deposited at RBG Kew, with an accession number BI 20128.
Extraction and isolation:
The plant material (900 g, dry weight) was coarsely ground and extracted 3 times with methanol at room temperature, 7 days each, with occasional stirring, and filtered through Whatman No 54 filter paper with the aid of vacuum. Extracts were combined and the solvent removed under vacuum at 40°C, yielding 97 g of dark gummy residue, which was then partitioned between n-butanol against water, 800 mL each, twice. The n-butanol phases were combined and brought to dryness (yield 33.7 g), and re-dissolved in methanol (1 L). To this solution, water (1 L) was slowly added while stirring vigorously over a period of 20 min and left to stand overnight at room temperature. The precipitate was removed by decanting and centrifuge. The dry residue from the supernatant (11.2 g) was fractionated over a Diaion HP-20 column (8 cm diam. × 23 cm), using a step gradient of methanol in water (3 L water, 2.5 L each of 20, 40, 60, and 80% methanol, and 100% methanol, 3 L), affording 6 fractions. The fraction eluted with 40% methanol (2.18 g) was subsequently chromatographed on a Sephadex LH-20 column (4 cm diam. × 23 cm), with 60%, 70% and 100% methanol, 500 mL each. Collection of the fractions (125 mL per fraction) was commenced after 150 mL-void volume. The fraction #4 (yield 123 mg) was further separated with HPLC using a methanol-acetonitrile-water mixture (9:1:40, v/v, isocratic) to yield (E)-p-coumaramide (9, 2.5 mg), (E)-caffeamide (10, 2.4 mg), (E)-ferulamide (12, 2.8 mg), 2,4-dihydroxybenzaldehyde (14, 7.8 mg), 2-hydroxy-4-methoxybenzoic acid (15, 5.4 mg), and 4-hydroxybenazldehyde (13) and syringic acid (16) as an approximately equimolar mixture (2.5 mg). N-Caffeoyldopamine (= caffedymine, 4, 4.3 mg) was purified from fraction #7 on HPLC with a methanol-water mixture (7:13, v/v, isocratic). The fraction eluted with 60% methanol (1.60 g) from the Diaion HP-20 column was chromatographed on a Sephadex LH-20 column (4 cm diam. × 22 cm), with 60%, 75%, 90% and 100% methanol, 500 mL each. Fractions were collected every 125 mL, after an initial void of 120 mL. The fraction #4 from this column (154.8 mg) was further separated with HPLC (methanol-water, 21:29, isocratic) to yield N-feruloyl-3-O-methyldopamine (6, 4.7 mg), portulacaldehyde (7, 4.3 mg) and ferulic acid (11, 12.6 mg). Fraction #5 (119.4 mg) afforded N-p-coumaroyltyramine (1, 4.8 mg) , N-feruloyltyramine (3, 16.2 mg), N-caffeoyl-4-O-methyldopamine (5, 9.7 mg), p-coumaric acid (8, 12 .0 mg) and 11 (10.7 mg) , and fraction #6 (68.5 mg) gave N-caffeoyltyramine (2, 11.3 mg) and further amounts of 1 (5.9 mg), 4 (7.0 mg) and 5 (3.5 mg) with HPLC (methanol-water, 2:3, v/v, isocratic). 
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